Advertisement

SPNE

SeaSpine Holdings Corporation

Healthcare

Set alert

Price alert · SPNE

All alert types
9.54 0.00 0.00%
As of Jan 4, 2023
8.43 Day range 9.67

52-week range unavailable

Open
8.83
Prev close
9.54
Mkt cap
360.18M
Vol
1.16M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
8.43
High
9.67
Forward P/E
-7.57
Beta
1.30
Short ratio
1.80
Inst. own
72.72%
Dividend
0.00
Ex-div date
Earnings
Nov 1, 2022
50-d avg
7.27
200-d avg
7.31
1y target
15.42

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for SPNE has not been loaded yet. Try again in a moment.

Key statistics

Market cap
360.18M
Enterprise value
351.50M
Trailing P/E
0.00
Forward P/E
-7.57
PEG ratio
1.12
Price / sales
1.57
Price / book
1.29
EPS (TTM)
-1.63
Beta
1.30
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-28.22%
Revenue (TTM)
229.75M
Revenue growth
44.60%
Free cash flow
-57.94M
Total cash
46.76M
Total debt
43.35M
Return on equity
-21.57%
Shares outstanding
37.76M
Short % of float
1.16%
50-day average
7.27
200-day average
7.31

Analyst view

Consensus: buy

Buy
Price target (mean) 15.42 +61.6% upside
Target (low)
6.75
Target (mean)
15.42
Target (high)
26.25
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Nov 1, 2022

Expected Nov 1, 2022. Consensus EPS estimate -0.39.

Earnings history

Financials — quick view

All financials
SPNE Revenue — quarterly 67.15M
2018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022
SPNE Net income — quarterly -15.50M
2018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022
SPNE EPS — quarterly -0.42
2018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022

Earnings

SPNE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 1, 2022Sep 1, 2022-0.30———
Aug 2, 2022Jun 1, 2022-0.35———
May 3, 2022Mar 1, 2022-0.35———
Mar 11, 2022Dec 1, 2021-0.36———
Oct 28, 2021Sep 1, 2021-0.31———
Aug 2, 2021Jun 1, 2021-0.35———

Upgrades / downgrades

SPNE analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2022Truist SecuritiesdownBuyHold
Aug 3, 2022Piper Sandlermain—Overweight
Jul 20, 2022Truist Securitiesmain—Buy
Mar 14, 2022Stifelmain—Buy
Mar 14, 2022Piper Sandlermain—Overweight
Dec 21, 2021Truist Securitiesmain—Buy

About SeaSpine Holdings Corporation

As of January 4, 2023, SeaSpine Holdings Corporation was acquired by Orthofix Medical Inc. SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
seaspine.com

News

Your note

Sign in to keep a note on SPNE — it syncs with the Stock Master app.

Insider holders

SPNE insider holders
InsiderRelationLatest transactionDateShares held
BENNY PAUL SOfficer and TreasurerConversion of Exercise of derivative securityDec 29, 202220,950
BOSTJANCIC JOHN JChief Financial OfficerConversion of Exercise of derivative securityDec 29, 2022102,563
BRADLEY KEITHDirectorStock Award(Grant)May 31, 202288,592
CIRINO DENNISOfficerConversion of Exercise of derivative securityDec 29, 202248,556
KERAN PATRICK LGeneral CounselConversion of Exercise of derivative securityDec 29, 202269,628
LIPSCHULTZ TYLER POfficerConversion of Exercise of derivative securityDec 29, 2022131,284

Institution ownership

SPNE institution ownership
Holder% heldSharesValueReported
First Light Asset Management, LLC19.00%7,067,57267.42MSep 29, 2022
Blackrock Inc.6.99%2,601,16624.82MSep 29, 2022
Avidity Partners Management, LP5.40%2,010,00019.18MSep 29, 2022
Vanguard Group, Inc. (The)4.34%1,614,66515.40MSep 29, 2022
Emerald Advisers, LLC2.46%915,9718.74MSep 29, 2022
Driehaus Capital Management, LLC2.44%907,7078.66MSep 29, 2022

Fund ownership

SPNE fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.58%961,6749.17MSep 29, 2022
iShares Russell 2000 ETF2.15%801,7147.65MNov 29, 2022
Vanguard Extended Market Index Fund1.23%458,5084.37MSep 29, 2022
AMG GW&K Small Cap Value Fund1.05%390,6883.73MSep 29, 2022
iShares Russell 2000 Value ETF1.02%378,6133.61MNov 29, 2022
Financial Investors Tr-Emerald Growth Fund1.01%376,0353.59MOct 30, 2022
Advertisement